articles about probiotic in Articles

A simple management strategy can have an impact on the piglet’s most challenging time in life: the weaning period.

The reader should be aware that in microbiome research correlation does not imply causation.

Eubiotics are seen as alternatives to things like zinc and antibiotic growth promotors for farms that can not use them, but if the global trend is that those products are no longer going to be available, should they be used as baseline?

Management, timing, diet selection, and monitoring gut health all are factors to think about when considering probiotics for your operation.

Factors to consider when determining if probiotics will help achieve your farm's objectives in terms of growth, health, and animal well-being.

This article reviews nutritional strategies to achieve a more efficient digestion and absorption of nutrients, which in turn will promote intestinal health.

Increased sows feed consumption, protection against piglet diarrhea, meat quality improvement and many more…

How can we promote a healthier microbiota, favorable for the pig and for its productivity? And, when is the best time to get it?

Probiotics and amino acids to improve the intestinal barrier. Omega-3 fatty acids, plasma, probiotics, prebiotics, etc... to enhance the immune response.

The objective of this article is to critically assess the use of probiotics in the post-weaning phase, and provide few suggestions to improve results when using probiotics in weanlings.

Combining the use of low levels of dietary protein with highly digestible protein sources and certain probiotics can be a good strategy in the face of the increasing restrictions on the use of antibiotics in feed.

We need to understand what is happening and what the circumstances are that cause bacteria that are also present in the microbiota of healthy piglets to multiply in such a way that they are capable of causing diarrhoea.

The feeding practices, the choice of the raw materials and the addition of additives have the potential of modulating the GI microbiota, reducing the energy cost for maintenance and also controlling the pathogenic bacteria.

The establishment of normal gut microbial communities can also prevent the colonization of pathogenic microorganisms.

Our research model has been a short chain fructooligosaccharide (scFOS) fed to swine. This compound was selected because it was identified in human and swine milk, was shown to have health benefits in human infants and patients recovering from intestinal anastomosis. The health benefit was believed to occur via the trophic effect of scFOS on the Bifidobacteria population.